Borda-Borda, M. (. G., Castellanos-Perilla, N. (., Tovar-Ríos, D. (. A., Oesterhus, R. (., Soennesyn, H. (., & Aarsland, D. (. (2021). Polypharmacy is associated with functional decline in Alzheimer's disease and Lewy body dementia.

Borda-Borda, M.G. (Miguel German)|||/items/681ecdf1-0f23-4003-a702-417198fd228d, N. (Nicolas)|||/items/537b2708-bf73-4deb-b2c1-758c0e506e6d Castellanos-Perilla, D.A. (Diego Alejandro)|||/items/1aaf0d54-35e3-4a37-9a7e-b3084b7538ba Tovar-Ríos, R. (Ragnhild)|||/items/745febe4-4336-42ad-9411-ab32b8b536bb Oesterhus, H. (Hogne)|||/items/64ddd66b-47c3-478d-9106-124368eb5a55 Soennesyn, and D. (Dag)|||/items/7f4024e7-2d11-43cf-8b41-29752ddf75e1 Aarsland. Polypharmacy Is Associated With Functional Decline in Alzheimer's Disease and Lewy Body Dementia. 2021.

Borda-Borda, M.G. (Miguel German)|||/items/681ecdf1-0f23-4003-a702-417198fd228d, et al. Polypharmacy Is Associated With Functional Decline in Alzheimer's Disease and Lewy Body Dementia. 2021.